Related Experiment Video

Updated: Jul 15, 2025

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.5K

Epigenetic Regulators Open the Door to SCLC Plasticity

Margaret C Weber1, Luke T Izzo1, Trudy G Oliver1

  • 1Department of Pharmacology & Cancer Biology, Duke University, Durham, North Carolina.

Cancer Research
|September 27, 2023
PubMed

Insights

Loss of KDM6A in small-cell lung cancer (SCLC) promotes plasticity between molecular subtypes by altering chromatin accessibility. This epigenetic regulation highlights histone methylation as a key factor in SCLC therapeutic resistance.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Small-cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with limited therapeutic options and a poor prognosis.
  • SCLC exhibits significant molecular plasticity, transitioning between subtypes defined by transcription factors like ASCL1 and NEUROD1, impacting treatment responses.
  • While MYC is known to drive the ASCL1-to-NEUROD1 transition, other mechanisms controlling SCLC plasticity are not well understood.

Purpose of the Study:

  • To investigate the role of KDM6A, a histone lysine demethylase, in regulating SCLC plasticity.
  • To explore the epigenetic mechanisms underlying SCLC's ability to transition between molecular states.
  • To develop novel therapeutic strategies by understanding SCLC plasticity.

Main Methods:

  • Utilized a genetically engineered mouse model of SCLC with KDM6A loss.
  • Analyzed chromatin accessibility and epigenetic landscapes.
  • Characterized the impact of KDM6A loss on SCLC molecular subtypes and plasticity in vivo.

Main Results:

  • KDM6A loss in SCLC significantly alters chromatin accessibility.
  • Loss of KDM6A enhances the potential for ASCL1-to-NEUROD1 plasticity in vivo.
  • Histone methylation was identified as a critical regulator of SCLC plasticity through epigenetic landscape characterization.

Conclusions:

  • KDM6A loss is a novel driver of SCLC plasticity, impacting its therapeutic vulnerabilities.
  • Epigenetic modifications, particularly histone methylation, play a crucial role in regulating SCLC plasticity.
  • These findings offer a new model for SCLC plasticity research and identify potential epigenetic targets for improved therapies.

More Related Videos

CRISPR-Mediated Reorganization of Chromatin Loop Structure09:20

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

12.6K
Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation09:07

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation

Published on: June 21, 2016

8.2K

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K